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Abstract
Background: The assembly of neural circuits requires the concerted action of both genetically determined and
activity-dependent mechanisms. Calcium-regulated transcription may link these processes, but the influence of
specific transcription factors on the differentiation of synapse-specific properties is poorly understood. Here we
characterize the influence of NeuroD2, a calcium-dependent transcription factor, in regulating the structural and
functional maturation of the hippocampal mossy fiber (MF) synapse.
Results: Using NeuroD2 null mice and in vivo lentivirus-mediated gene knockdown, we demonstrate a critical role
for NeuroD2 in the formation of CA3 dendritic spines receiving MF inputs. We also use electrophysiological
recordings from CA3 neurons while stimulating MF axons to show that NeuroD2 regulates the differentiation of
functional properties at the MF synapse. Finally, we find that NeuroD2 regulates PSD95 expression in hippocampal
neurons and that PSD95 loss of function in vivo reproduces CA3 neuron spine defects observed in NeuroD2 null
mice.
Conclusion: These experiments identify NeuroD2 as a key transcription factor that regulates the structural and
functional differentiation of MF synapses in vivo.
Background
Excitatory neurotransmission in the central nervous sys-
tem is mediated by post-synaptic protrusions called den-
dritic spines [1]. Spines are highly dynamic structures
and their growth, stabilization and elimination are pro-
posed to underlie the effects of experience on both the
developing and adult brain [2,3]. The effects of neuronal
activity on spine morphology are mediated by calcium
signaling, which can have acute effects by modulating
the existing proteins at the synapse, or can lead to last-
ing change by transcription-dependent mechanisms.
Relatively little is known about how specific transcrip-
tion factors act to coordinate activity-dependent signal-
ing pathways to influence genes involved in spine
morphogenesis.
To identify molecular mediators of activity-dependent
development, we previously carried out a screen for cal-
cium-dependent transcription factors expressed in
cortical neurons [4]. One gene identified in this screen
was the basic helix-loop-helix (bHLH) transcription fac-
tor Neurogenic differentiation factor 2 (NeuroD2).
Although bHLH genes are best characterized for their
role in cell fate determination [5], NeuroD2 is expressed
exclusively in post-mitotic neurons [6]. Consistent with
a role in activity-dependent development, we found that
NeuroD2 regulates thalamocortical connectivity in the
mouse somatosensory cortex [7]. Similarly, NeuroD2
has recently been implicated in the differentiation of
pre-synaptic terminals using a cerebellar slice co-culture
system [8]. These observations motivated us to ask
whether NeuroD2 regulates the morphological differen-
tiation of excitatory synapses.
We decided to investigate the role of NeuroD2 in hip-
pocampal synapse formation as hippocampal connectiv-
ity is well understood, and distinct classes of synapses
can be distinguished using anatomical and functional
criteria. One of the most complex synapses in the hip-
pocampus is the mossy fiber synapse, which mediates
connectivity between the dentate gyrus (DG) and CA3
regions. This synapse develops entirely during the
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specialization of mossy fiber (MF) synapses is character-
ized by unique multi-headed dendritic spines termed
thorny excrescences (TEs), which are engulfed by mas-
sive pre-synaptic MF boutons [11,12]. Functionally, MF
synapses are characterized by a low probability of
release, short-term frequency-dependent facilitation and
a unique form of NMDA receptor (NMDAR)-indepen-
dent, pre-synaptically expressed long-term potentiation
[13]. In contrast, distal associational/commissural CA3
synapses form onto classic, mushroom shaped spines,
have a higher probability of release and exhibit
NMDAR-dependent and post-synaptically expressed
long-term potentiation [13].
Here, using NeuroD2 null mice and targeted in vivo
knockdown of NeuroD2, we investigate the function of
this transcription factor on the maturation of the MF
synapse. We find that NeuroD2 regulates the elabora-
tion of TE spine heads and the functional differentiation
of MF synaptic properties. NeuroD2 also regulates the
level of the synaptic scaffolding molecule PSD95 in the
developing hippocampus, suggesting that NeuroD2
might influence synaptic structure and function by regu-
lating the expression of scaffolding proteins. Consistent
with this possibility, PSD95 loss of function in vivo phe-
nocopies the effect of loss of NeuroD2. These results
identify NeuroD2 as a key transcriptional regulator of
MF connectivity and provide mechanistic insight into
the process of MF synapse maturation.
Results
Genetic deletion of NeuroD2 leads to a decrease in
thorny excrescence spine heads on CA3 neurons
NeuroD2 is expressed in the developing cortex and hip-
pocampus during synapse formation [7,14]. To deter-
mine if NeuroD2 plays a role in the development of
synaptic connectivity in the hippocampus, we analyzed
mice in which NeuroD2 has been deleted by homolo-
gous recombination [15]. The hippocampus of NeuroD2
null mice is somewhat smaller with a more rounded
shape as early as P7, but exhibits normal regional and
cellular differentiation based on Hoechst nuclear stain
a n de x p r e s s i o no ft h eD G / C A 1m a r k e rC T I P 2( F i g u r e
1A-D). DG axons called mossy fibers extend from DG
granule cells and form synapses onto the apical den-
drites of CA3 neurons during postnatal hippocampal
development. To determine if DG-CA3 synapses were
disrupted in the absence of NeuroD2, we examined the
morphological development of CA3 dendritic spines.
MF boutons form synapses onto unique dendritic
spines, called TEs because of their multi-headed struc-
ture with many spine heads emerging from a common
neck. An important consideration when examining
dynamic structures such as spines is to capture them in
their native state. The morphology of some spines is not
maintained in vitro and spines undergo rapid dynamic
responses when sectioned for live cell fills [16]. Thus, to
investigate TE formation, we utilized sharp microelec-
trodes for the current driven injection of Lucifer Yellow
(LY) dye into CA3 neurons in fixed tissue slices from
transcardially perfused wild-type (WT) and NeuroD2
null mice. Injected dye completely filled dendritic arbors
and clearly labeled TE spines on the proximal apical
dendrite (Figure 1E, F). CA3 neurons were filled at post-
embryonic day (P)7, P14 and P21 in WT and NeuroD2
null littermates (Figure 1F). Multi-headed TE spines
c l u s t e ro n t op a t c h e so fC A 3d e n d r i t e s ,s ot oa n a l y z e
spine density we developed a method to quantify indivi-
dual TE spine heads using high-resolution image stacks
created using confocal microscopy. In WT mice, there
was a large increase in TE spine head density between
P7 and P14, with a slightly lower density of spine heads
at P21 (Figure 1G). NeuroD2 null mice showed no sig-
nificant difference in TE spine head density compared
to controls at P7, but failed to fully elaborate TEs
between P7 and P14 when compared with WT litter-
mates, an effect that persisted at P21 (Figure 1G). There
were no significant differences in TE spine head width
across ages or between conditions (Figure 1H). Thus,
the normal elaboration of TE spine heads depends on
NeuroD2 function during synapse development.
Excitatory synapses onto CA3 neurons in the hippo-
campus are laminarly distributed such that MF inputs
from the DG are formed proximal to the cell body,
while CA3-CA3 synapses and entorhinal cortex to CA3
synapses form on the distal dendritic arbor. To deter-
mine if the effects of eliminating NeuroD2-mediated
transcription were specific to TE elaboration, we exam-
ined classical spine density in the same cell fills on distal
dendrites, where inputs are largely from other CA3 neu-
rons (Figure 2A). There was a small but significant
reduction in distal spine density for both developmental
time points, but no effect on distal spine head diameter
(Figure 2B, C). These data demonstrate that NeuroD2
also functions to regulate distal spine density, although
the effect is not as large as that observed on TE spine
elaboration (Figure 1G).
In addition to CA3, NeuroD2 is also highly expressed
in both DG and CA1 excitatory neuronal populations. To
determine if loss of NeuroD2 resulted in a global
decrease in spine density in the hippocampus we also
analyzed spine density for these subtypes of hippocampal
excitatory neurons. Compared to WT littermates, Neu-
roD2 null mice exhibited a marked reduction in DG neu-
ron spine density (Figure 2D), but CA1 spine density was
unaffected (Figure 2E). These data suggest that NeuroD2
is not required for spine formation in general, but regu-
lates the development of specific classes of synapses.
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Page 2 of 14NeuroD2 functions cell-autonomously to regulate TE
development in vivo
Experiments with NeuroD2 null mice do not reveal
whether the defect in TE morphology results from a loss
of NeuroD2 function in DG or CA3 neurons. To identify
the cells in which NeuroD2 function is required, we gener-
ated a short hairpin RNA (shRNA) construct against
NeuroD2 to cell autonomously reduce NeuroD2 function.
This shRNA cassette, when cloned into a lentiviral vector
simultaneously expressing green fluorescent protein
(GFP), knocked down myc-tagged NeuroD2 expression in
293T cells by greater than 95%, with no effect on Neu-
roD1, which differs by only four nucleotides in the target
region and has the greatest homology with NeuroD2
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Figure 1 Genetic deletion of NeuroD2 leads to reduced density of thorny excrescence spine heads. (A, C) Hoechst nuclear staining of
the hippocampus from post-embryonic day (P)21 littermate, WT and NeuroD2 null (knockout (KO) OK) mice. (B, D) CTIP2 immunostaining,
specific for DG and CA1 neuron nuclei, shown for the same sections as in (A, C). (E) P21 CA3 pyramidal neuron filled in coronal hippocampal
section from transcardially perfused mouse by targeted microinjection of Lucifer Yellow dye. Inset indicates individual TE spine heads in a single
confocal plane (white arrowheads). (F) Representative proximal dendritic segments with TE spines in WT and NeuroD2 null mice (KO) at P7, P14
and P21 time points. (G) TE elaboration quantified by counting the density of individual spine heads on primary and secondary dendritic
branches in 60X confocal stacks (P7, n = 6 per condition; P14, 21, n ≥ 15). (H) Individual TE spine head width quantified in confocal stacks as the
width of the head in the confocal plane where it was largest (n ≥ 6 per condition). *P < o.05, t-test. Scale bars: 130 μm (A); 75 μm (E); 5 μm (F,
I). Error bars represent ± standard error of the mean. N.S., not significant.
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Page 3 of 14amongst bHLH transcription factors (Figure 3E). To deter-
mine the effect of NeuroD2 knockdown on MF synapse
development in vivo, we injected lentivirus expressing
shNeuroD2 and GFP or GFP alone into the CA3 region of
P5 rat pups. CA3 neurons were clearly labeled with lenti-
viral GFP expression in slices cut from transcardially-per-
fused rats at P16 (Figure 3A). To accurately quantify spine
morphology, we developed a technique for targeted micro-
injection of LY dye into GFP labeled neurons guided by
fluorescence microscopy. The LY signal was amplified
with an anti-LY antibody (Figure 3B) and the filled neuron
was confirmed post hoc by immunostaining for GFP
(Figure 3B-D). TE spines were clearly visible on CA3 neu-
rons filled in this manner (Figure 3C). In vivo shRNA-
mediated knockdown of NeuroD2 reduced the density of
TE spine heads approximately 40%, similar to the effect
observed in NeuroD2 null mice, indicating that NeuroD2
can cell-autonomously regulate the structural elaboration
of TE spine heads (Figure 3F). Interestingly, quantification
of distal classical spines did not show a significant reduc-
tion between control and NeuroD2 shRNA virus (Figure
3G). These data suggest that either NeuroD2 regulates dis-
tal spine density in a non-cell autonomous manner or that
NeuroD2 function is critically and specifically involved in
TE elaboration during the time window of our acute
manipulation.
Functional maturation of mossy fiber synaptic properties
is impaired in NeuroD2 nulls
To examine the effect of loss of NeuroD2 on MF func-
tional properties, we carried out voltage-clamp record-
ings from CA3 neurons while stimulating MF axons in
acute brain slices from WT and NeuroD2 null mice.
Current responses to MF stimulation showed short
latencies, rapid rise times and underwent strong paired-
pulse facilitation (PPF), all of which are key features of
monosynaptic responses at this synapse [17] (Figure 4A,
B). Additionally, MF-evoked synaptic responses were
strongly suppressed by perfusion with L-CCG (10 μM),
a group II metabotropic glutamate receptor (mGluR)
agonist that acts on mGluRs expressed specifically at
MF terminals to suppress neurotransmitter release and
h a sb e e nu s e di nan u m b e ro fs t u d i e st oc o n f i r mM F
synapse identity (Figure 4A) [18-23]. The amplitude and
response kinetics of CA3 neurons elicited by MF stimu-
lation were similar between WT and NeuroD2 null con-
ditions (data not shown).
The postnatal maturation of glutamatergic synapses is
marked by a large increase in the ratio of current car-
ried by AMPA receptors (AMPARs) in relation to
NMDARs (AMPAR/NMDAR ratio) [24]. This ratio is
therefore commonly used to measure the state of gluta-
matergic synapse maturation. We measured AMPAR/
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Figure 2 Genetic deletion of NeuroD2 leads to cell-type-specific effects on classic spine density. (A) Representative CA3 tertiary dendritic
segments showing classical spines at P14 and P21. (B) Quantification of mean classical spine density on CA3 tertiary segments (n ≥ 9 per
condition). (C) Quantification of mean CA3 classical spine head width (n ≥ 9 per condition). (D) Quantification of DG spine density (WT, n = 7;
knockout (KO), n = 8). (E) Quantification of CA1 spine density (WT, n = 13; KO, n = 7). *P < 0.05, ***P < 0.001, t-test. Scale bar: 5 μm. Error bars
represent ± standard error of the mean.
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Page 4 of 14NMDAR-mediated current ratios at the MF synapse in
WT and NeuroD2 null brain slices. To determine the
AMPAR-mediated current we recorded the peak inward
current evoked by MF stimulation at -70 mV, at which
level the NMDAR-mediated current is blocked by mag-
nesium ions. The AMPAR-mediated current was then
divided by the current amplitude measured 50 ms post-
stimulus and at a holding potential of +50 mV, where
current is largely mediated by NMDARs. The AMPAR/
NMDAR ratio was significantly reduced in NeuroD2
null mice compared to littermate controls, suggesting
that the proper functional maturation of the DG-CA3
synapse requires NeuroD2 (Figure 4C).
A characteristic feature of the MF to CA3 synapse is a
strong PPF, which is a measure of presynaptic function
and scales inversely with the probability of release at a
synapse. In order to determine if PPF was affected in
NeuroD2 null mice we delivered two stimuli to the MF
pathway with an interstimulus interval set at 100 ms.
The facilitation ratio was calculated at a holding poten-
tial of -70 mV by taking the peak amplitude of the sec-
ond excitatory postsynaptic current and dividing by the
peak of the first excitatory postsynaptic current (Figure
4B). The PPF ratio was nearly doubled for NeuroD2
null MF synapses when compared to controls (Figure
4D), suggesting that MF synapses in NeuroD2 null mice
exhibit a significantly lower probability of release than
WT synapses. These observations further support an
important role of this transcription factor in the proper
developmental maturation of the MF to CA3 synapse.
NeuroD2 regulates MF-CA3 synaptic connectivity in vitro
To determine how loss of NeuroD2 affects the localiza-
tion of synaptic proteins, we next analyzed hippocampal
neuronal cultures from WT and NeuroD2 null litter-
mates. MF synapses in vitro were defined as the co-loca-
lization of the MF specific pre-synaptic marker
synaptoporin (SPO), the excitatory pre-synaptic marker
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Figure 3 NeuroD2 functions cell-autonomously to regulate thorny excrescence development in vivo. (A) Immunohistochemistry (IHC) for
lentiviral GFP expression, pups injected at P5 and perfused at P16. (B) GFP-positive neuron filled with Lucifer Yellow (LY) dye and processed for
IHC against LY (red); GFP-positive neurons are green. (C) Higher magnification image of LY IHC showing TE spines. (D) Overlaid image of LY and
GFP IHC, demonstrating co-localization. (E) Immunoblot for myc-tagged NeuroD2 and NeuroD1 co-transfected with either NeuroD2 shRNA
expressing lentiviral vector or control vector into 293T cells for 48 hours. Control is blotting for anti-GAPDH for same blot. Loading is duplicate
wells. (F) Quantification of TE spine head density on primary and secondary dendrites of vector and shNeuroD2 lentivirus-infected neurons filled
with LY dye (shVector, n = 14; shNeuroD2, n = 15) (G) Quantification of classical spine density on tertiary dendrites of lentivirus-infected neurons
filled with LY dye (shVector, n = 15; shNeuroD2, n = 7). *P < 0.05, t-test. Scale bar: 50 μm (A, B); 5 μm (C, D). Error bars represent ± standard
error of the mean.
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Page 5 of 14vesicular glutamate transporter 1 (Vglut1) and the post-
synaptic scaffolding molecule PSD95 (Figure 5A-H)
[25,26]. Consistent with the morphological analysis in
vivo, there was a highly significant reduction in the den-
sity of MF synapses on the large proximal dendrites of
pyramidal shaped neurons in NeuroD2 null cultures
compared to controls (Figure 5I).
To specifically address the role of NeuroD2 in regulat-
ing MF synapse density on CA3 neurons, we combined
staining for the pre-synaptic markers SPO and Vglut1
with the cell-type specific marker CTIP2. CTIP2 is a
transcription factor that is highly expressed in dentate
granule neurons and CA1 pyramidal neurons, but is
completely absent from CA3 pyramidal neurons (Figure
1C, D); therefore, CTIP2-negative cells are presumptive
CA3 neurons [26,27]. Immunohistochemistry for CTIP2
in vitro reveals two clear populations of neurons, puta-
tive CA1 and DG neurons with CTIP2 staining that
includes the nucleus (Figure 5R, V), and putative CA3
neurons, which completely lack CTIP2 nuclear staining
(Figure 5J, N). We analyzed SPO and Vglut1 co-localiza-
tion on these two classes of neurons to assess the den-
sity of DG pre-synaptic terminals onto these
postsynaptic populations (Figure 5J-Y). Consistent with
a CA3 neuron identity, CTIP2-negative neurons in cul-
ture received greater numbers of MF terminals onto
their proximal dendrites when compared to CTIP2-posi-
tive neurons (Figure 5Z). CTIP2-negative neurons (pre-
sumptive CA3 neurons) from NeuroD2 null cultures
showed an approximately 40% reduction in DG
terminals, while there was no difference in DG terminals
onto incorrect target cells that were CTIP2 positive
(Figure 5Z). These data are consistent with our finding
of decreased TE density in vivo and indicate that Neu-
roD2 is specifically required for the formation of DG
terminals onto CA3 neurons.
Regulation of synaptic scaffolding proteins by NeuroD2
Transcription factors influence the structure and func-
tion of neurons via their regulation of specific sets of
genes within transcriptional networks. To explore the
possibility that NeuroD2 regulates the expression of
synaptic proteins, we examined the levels of synaptic
scaffolding molecules known to regulate the structure
and function of synapses. Using western blot analysis
with hippocampal lysates we found that the levels of the
membrane-associated guanylate kinase synaptic scaffold-
ing molecules SAP102 and PSD95 were reduced in Neu-
roD2 null mice compared to littermates at both P14 and
P21 by greater than 50% (Figure 6A-C). Similarly, relative
expression of PSD95 mRNA was significantly reduced in
NeuroD2 null neurons in vitro compared to WT controls
by quantitative PCR analysis (Figure 6D). Importantly,
several other synaptic proteins were not reduced in the
NeuroD2 null hippocampus based on immunoblot analy-
sis (Additional file 1). These observations indicate that
expression of two key scaffolding proteins, PSD95 and
SAP102, are strongly influenced by NeuroD2 levels and
suggest that NeuroD2 may exert its effects on MF-CA3
synapse maturation via regulation of these molecules.
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Figure 4 Functional maturation of mossy fiber synaptic properties is impaired in NeuroD2 null mice. (A) Representative whole cell
voltage-clamp recording in an acute sagittal slice from P14 to P16 mouse while stimulating MF axons. A representative evoked synaptic current
is shown at a holding potential of -70 mV, before and after perfusion with L-CCG (10 μM). (B) Evoked MF responses demonstrating strong
paired-pulse facilitation and showing currents recorded at holding potentials of +50 and -70 mV. (C) Quantification of AMPA receptor (AMPAR)/
NMDAR-mediated current ratios at the MF synapse, measured as the peak current at -70 mV relative to the peak current 50 ms into the
response at +50 mV (WT = 6.08 ± 0.70, n = 27; knockout (KO) = 3.86 ± 0.68, n = 22). (D) Quantification of facilitation ratios measured as peak
current of second response relative to first response at a holding potential of -70 mV and a 100 ms inter-stimulus interval (ISI; WT = 2.26 ± 0.21,
n = 9; KO = 3.95 ± 0.60, n = 11). *P < 0.05, t-test. Error bars represent ± standard error of the mean.
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Page 6 of 14To determine if the reduction in PSD95 levels in Neu-
roD2 null mice might account for the observed TE
spine defect, we examined the effect of PSD95 loss of
function using lentiviral expression of an shRNA con-
struct (shPSD95). The PSD95 shRNA and lentiviral vec-
tor we used for these experiments have been extensively
analyzed to confirm both efficacy and specificity [28],
and we confirmed that this PSD95 shRNA led to
significant knockdown of PSD95 expressed in 293T cells
(Figure 6G). To assess the role of PSD95 on TE devel-
opment in vivo, we did targeted injections of lentivirus
expressing shPSD95 and GFP or GFP alone into the
C A 3r e g i o no fP 5r a tp u p s .K n o c k i n gd o w nP S D 9 5
expression in the developing rat hippocampus, from P5
to P16, was sufficient to reduce elaboration of TE spines
by nearly 50% (Figure 6E-G), which is similar to the
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Figure 5 DG-CA3 synapses are reduced in NeuroD2 null neurons in vitro. Hippocampal neurons from P0 WT and NeuroD2 null mice were
cultured at low density on a glial monolayer and fixed for immunostaining at 16 days in vitro for the following markers: (A, E) PSD-95; (B, F)
synaptoporin (SPO); (C, G) Vglut1; (D, H) merged images of staining for synaptically localized proteins with PSD-95 in red, SPO in green and
Vglut1 in blue. (I) Quantification of DG synapse density by triple co-localization of synaptic markers on large primary dendrites (WT, n = 25;
knockout (KO), n = 21). Cultures were also immunostained with the DG- and CA1-specific nuclear marker CTIP2 to investigate the localization of
synaptic terminals onto putative hippocampal CA3 neurons in vitro. (J, M, N, Q) CTIP2-negative neurons, putative CA3 neurons, lacked staining
in their nucleus; the asterisk indicates lack of nuclear staining for CTIP2. (R, U, V, Y) CTIP2-positive neurons, non-CA3 neurons, had staining that
included the nucleus. (K-M, O-Q, S-U, W-Y) SPO and Vglut1 immunohistochemistry were used to localize MF terminals onto the proximal
dendrites of these neuron types as indicated. (Z) Quantification of DG terminal density onto CTIP2-negative, putative CA3 neurons (WT, n = 14;
KO, n = 16), and CTIP2-positive non-CA3 neurons (WT, n = 9; KO, n = 8). ***P < 0.01, t-test; n.s., not significant. Scale bars: 10 μm. Error bars
represent ± standard error of the mean. (Note that the secondary antibody used to detect CTIP2 cross-reacts with an additional primary
antibody against CamKII used as a dendritic marker, leading to dendritic signal in the red channel that did not interfere with assessing nuclear
CTIP2 signal).
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effect, we developed a second shRNA-expressing con-
struct targeted against an independent region of the
PSD95 gene. In addition to knockdown of PSD95 exo-
genously expressed in 293T cells, we further confirmed
knockdown of endogenous protein in cultured hippo-
campal neurons for this construct (Figure 6I). For these
experiments we utilized in utero co-electroporation of
the shRNA-expressing construct with a construct
expressing membrane bound GFP compared with
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Figure 6 NeuroD2 regulates expression of PSD95 and SAP102 in the developing hippocampus. (A) Representative immunoblots against
PSD95 and SAP102 in hippocampal lysates from WT and NeuroD2 null littermates at P14 and P21. Loading control is immunoblotting for b-
tubulin. (B) Quantification of SAP102 relative expression (n = 3 littermate pairs). (C) Quantification of PSD95 relative expression as in (B) (n = 3
littermate pairs). (D) Quantitative PCR analysis of NeuroD2 and PSD95 mRNA expression in WT and NeuroD2 null cultures (n = 5 and n = 6,
respectively). (E) LY filled, shVector-infected CA3 neuron. (F) LY filled, shPSD95-infected CA3 neuron. (G) Immunoblot for mCherry-tagged PSD95,
co-transfected with PSD95 shRNA expressing lentiviral vector or control vector into 293T cells for 48 hours (duplicate experiment). Control is
blotting with anti-GAPDH. (H) Quantification of TE spine head density between conditions (shVector, n = 9; shPSD95, n = 8). (I) Immunoblot for
endogenous PSD95 in neuronal culture infected with a lentivirus expressing a second shPSD95 construct. (J) Quantification of TE spine head
density with an independent construct, shPSD95-2 (control, n = 12; shPSD95-2, n = 15). *P < 0.05, **P < 0.01. Scale bar: 5 μm. Error bars
represent ± standard error of the mean. KO, knockout.
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demonstrated an shRNA-dependent decrease in the den-
sity of TE spine heads of similar magnitude, confirming
the role of PSD95 in the development of these post-
synaptic structures (Figure 6J). These experiments
demonstrate that PSD95 expression is reduced in the
absence of NeuroD2 and that PSD95 is critical for the
normal development of TE spines.
Discussion
The observations reported here identify NeuroD2 as a
key transcriptional regulator of MF synapse develop-
ment. In NeuroD2 null mice there is a marked decrease
in the density of TE spine heads on the proximal apical
dendrites of CA3 neurons. Lentiviral-mediated shRNA
knockdown of NeuroD2 in vivo further demonstrates
that NeuroD2 functions cell-autonomously to regulate
the elaboration of TE spine heads. Further, the similarity
in spine phenotypes resulting from loss of NeuroD2 and
PSD95, together with the observation that PSD95 levels
are significantly reduced in NeuroD2 nulls, suggests that
NeuroD2 exerts its effects on synapse differentiation at
least in part via regulation of the synaptic scaffolding
protein PSD95 (Figure 7).
Reduced TE elaboration in NeuroD2 nulls could
reflect either a decreased density of MF synapses or a
less mature state of synaptic differentiation, possibilities
that are not mutually exclusive. Hippocampal cultures
from NeuroD2 null mice show a large reduction in the
density of MF synapses as defined by the co-localization
of pre- and post-synaptic molecules. This experiment
distinguishes the NeuroD2 null phenotype from an axon
guidance defect as guidance mechanisms likely do not
function in dissociated cultures. The use of cell-type-
and synapse-specific markers demonstrates that Neu-
roD2 regulates the density of MF terminals on the prox-
imal dendrites of presumptive CA3 neurons in vitro
with no effect on MF terminal density onto incorrect
targets. These observations identify NeuroD2 as a criti-
cal regulator of DG-CA3 synapses and suggest that this
transcription factor is responsible for the differentiation
of MF-specific synaptic features.
Our electrophysiological recordings demonstrate that
the functional maturation of MF synaptic properties is
also disrupted in the absence of NeuroD2. The ratio of
AMPAR/NMDAR-mediated currents increases during
development [24,29-31]. Recordings made from CA3
neurons while stimulating MF inputs demonstrate a
reduction of AMPAR/NMDAR-mediated current ratio
in NeuroD2 null mice. NeuroD2 null mice also exhibit
an increased PPF ratio, indicating that NeuroD2 can
also likely function to regulate release probability at the
pre-synaptic terminal. These results point to a critical
role for NeuroD2 in the functional maturation of indivi-
dual MF-CA3 synapses.
That NeuroD2 regulates the expression of post-synap-
tic proteins such as PSD95 and SAP102 indicates that
these molecules may mediate the effects of NeuroD2 on
synaptic differentiation. PSD95 overexpression in vitro
drives increased spine density and head size [32]. How-
ever, loss of function experiments in vitro have yielded
mixed results on spine morphogenesis ([28] versus [33]).
Prior to this work, the role of PSD95 on in vivo spine
morphology has not been extensively studied, with most
studies done in vitro [32,33]. Similarly, very little is
known about the function of these molecules specifically
at the MF synapse. In our experiments, in vivo knock-
down of PSD95 in CA3 neurons leads to a cell-autono-
mous reduction in the developmental elaboration of TE
spines, mimicking the effect of NeuroD2 loss of function
experiments. These data indicate that reduced expres-
sion of PSD95 downstream of NeuroD2-regulated tran-
scription is likely to directly influence post-synaptic
morphology at the MF synapse in vivo.
PSD95 and SAP102 have also been demonstrated to
regulate the AMPAR content of developing synapses
[34], and may therefore underlie the reduced AMPAR/
NMDAR-mediated current ratio at MF synapses in the
.EURO$
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Figure 7 Diagrammatic representation of the proposed role of
NeuroD2 in thorny excrescence spine maturation. NeuroD2 is a
calcium-activated transcription factor that regulates the transcription
of the post-synaptic scaffolding molecule PSD95 amongst other
target genes. PSD95 expression downstream of NeuroD2 is part of a
pathway regulating the elaboration of TE spine heads during MF
synapse development. NeuroD2 also regulates the functional
maturation of glutamatergic currents at the MF synapse, an effect
that may relate to the role of PSD95 in modulating the AMPAR
content of developing synapses.
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to PSD95 and accumulates first at hippocampal synapses
in vivo [35,36]. Each molecule has differential effects
during synaptogenesis and synapse maturation. Knock-
down of SAP102 transiently impairs glutamatergic cur-
rents at P7 CA3-CA1 synapses in vivo,w h i l e
knockdown of PSD95 has no effect at P7, but dramati-
cally suppresses AMPAR accumulation at P16 [37].
Additional evidence from a number of studies indicates
synapse specific and developmentally regulated functions
of membrane-associated guanylate kinase scaffolds in
glutamatergic phenotype [28,34,38]. Coordinated regula-
tion of scaffolding molecules by NeuroD2 may reflect a
general mechanism by which transcription factors influ-
ence synaptic differentiation and maturation.
It is noteworthy that NeuroD2 appears to have both
cell-type- and synapse-specific effects. Our result indi-
cate that, in the absence of NeuroD2-mediated tran-
scription, DG and CA3 neuron spine density is
decreased while CA1 neuron spine density appears to be
intact. Interestingly, the most extensive study of spine
development in PSD95 null mice found no overall effect
on CA1 spine density, but a significant reduction in
spine density of entorhinal cortex neurons [39]. Given
that PSD95 is widely expressed in the hippocampus and
localizes to multiple synapse types, how might decreased
PSD95 expression downstream of NeuroD2 mediate
such specific effects? One intriguing possibility is that
PSD95 might act to bring together functional complexes
with unique constituents depending on synapse type or
cellular context, such that its loss of function yields dif-
ferential effects. This suggests that synapse-specific ana-
lysis of PSD95 interacting proteins may be fruitful in
identifying molecules that mediate synaptic specificity.
Our experiments exploring the effects of reduced
PSD95 expression in the hippocampus of NeuroD2 null
mice do not rule out the possibility that additional
molecules might also play a role in aspects of the synap-
tic phenotype. For example, expression of the cell adhe-
sion molecules SynCAM1 to -3 are developmentally
regulated by NeuroD2, and levels of SynCAM3 are
strongly reduced in the NeuroD2 null hippocampus at
both P14 and P21 (Additional file 2). Our analysis of
SynCAM1 and SynCAM3 null mice did not reveal a
decrease in TE spines (data not shown); however, these
molecules may contribute to other aspects of the Neu-
roD2 null phenotype.
Transcriptional regulation of synaptic connectivity has
recently been a topic of considerable interest. Greenberg
and colleagues [40-42] have demonstrated that specific
activity-regulated transcription factors are involved in
synapse elimination and inhibitory synapse formation.
More recently, Bonni and colleagues [8] have specifically
implicated NeuroD2 in a pathway regulating the
differentiation of pre-synaptic terminals in the cerebel-
lum. Our study further indicates a central role for Neu-
roD2 in the transcriptional regulation of synapse
differentiation. That NeuroD2 regulates the expression
of post-synaptic proteins in the hippocampus suggests
that decreased levels of these molecules might underlie
the structural and functional deficits observed in Neu-
roD2 null mice. NeuroD2 and other bHLH transcription
factors regulate gene expression by binding E-Box
sequences (CANNTG) upstream of transcriptional start
sites [43]. Both PSD95 and SAP102 have a number of
potential E-Box binding sites, which may act as Neu-
roD2 regulatory elements (Additional file 3). Further,
PSD95 expression is regulated by activity in the mouse
cochlea and is necessary for the in vitro maturation of
hippocampal synapses downstream of neuronal activity
[33,44]. The hippocampal MF synapse develops entirely
during the postnatal period and thus during a period
when an animal is exposed to a diverse set of environ-
mental influences [9,10]. The long-term effects of such
activity at the neuronal level are determined by calcium-
regulated transcription [42]. As a calcium-dependent
transcription factor, NeuroD2 may function as part of a
regulatory pathway matching PSD95 expression to the
level of synaptic activity seen by a particular neuron and
thereby contribute to activity-dependent synaptic
development.
Conclusion
Here we demonstrate a critical role for the transcription
factor NeuroD2 in the development of the hippocampal
MF synapse. We show PSD95 expression is reduced in
the absence of NeuroD2 and that this decrease pheno-
copies the effect of NeuroD2 loss of function on TE
development at the MF synapse. These observations
advance our understanding of the transcriptional control
of synaptic differentiation. Together with other studies
this work begins to provide a framework for how activ-
ity-dependent transcription factors can shape the orga-
nization of neural circuits.
Materials and methods
All experiments have been carried out under the Uni-
versity of California, San Diego’s Animal Care and Use
Committee guidelines.
Plasmids
For shRNA-mediated knockdown, candidate shRNA
sequences were purchased from Open Biosystems
(Lafayette, CO, USA) in the pLKO.1 expression vector
driving shRNA expression off the U6 promoter and
evaluated for efficacy and specificity. For shRNA-
mediated knockdown of NeuroD2, we used the follow-
ing sequence corresponding to nucleotides 911 to 931
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Mouse and rat NeuroD2 are 100% conserved in the tar-
get region for the shRNA. For in vivo knockdown of
NeuroD2 expression, the U6 promoter and shNeuroD2
sequence from PLKO.1 were cloned into the PacI site of
the lentiviral vector plasmid FCK(0.4)GW (a gift from
Dr Pavel Osten, Cold Spring Harbor Laboratory, Cold
Spring Harbor, NY), which contains a 0.4 kb fragment
of the mouse CaMKII promoter driving EGFP [45]. As a
control vector, we used FCK(0.4)GW alone. Myc-tagged
mouse NeuroD2 and NeuroD1 were expressed from the
pCS2+ plasmid off the CMV promoter. Validated lenti-
viral constructs expressing shRNA against PSD95 and
empty vector control expressing GFP alone were
obtained in the pLLox3.7 vector (a gift from Dr Roger
Nicoll, UCSF, San Francisco, CA). The shRNA sequence
for PSD95 was: TCACGATCATCGCTCAGTATA.
These constructs have been extensively validated for
efficacy and specificity in previous publications [28]. A
second independent PSD95 shRNA and GFP expressing
lentiviral construct in the pGIPZ vector (Open Biosys-
tems) was used for confirmation, for which the sequence
was CAGCACATCCCTGGAGATA. This second con-
struct or a control construct (FCK(0.4)GFP) was com-
bined with pFCK(0.4)mGFP, expressing membrane-
targeted GFP for in utero electroporation experiments.
Intracellular injection of Lucifer Yellow
Mice of either sex were anesthetized and transcardially
perfused with phosphate-buffered saline (PBS) followed
by 4% paraformaldehyde at pH 7.4 and post-fixed in 4%
paraformaldehyde for 1 hour on ice. Then, 100 μm
thick coronal sections were cut using a vibratome and
stored in PBS on ice. Penetrating microelectrodes were
pulled from standard borosilicate capillary glass with
filament (1 mm outer diameter/0.58 mm inner dia-
meter) and back-filled with LY dye (5%). Slices were
mounted on coverslips under PBS and CA3 neurons
were filled via iontophoresis under visual guidance. Sec-
tions were then post-fixed an additional 15 minutes
before being prepared for immunohistochemistry.
In utero electroporation
Timed-pregnant CD-1 white mice (Charles River, E15)
were anesthetized with 3% isoflurane. A small vertical
incision was made in the skin and abdominal wall and
embryos gently exposed. Each embryo was injected with
1t o2μl of DNA solution and 0.01% Fast Green into
the ventricles [46]. For spine analysis, pGIPZ-shPSD95
plasmid DNA or pFCK(0.4) was mixed with pFCK(0.4)-
mGFP DNA. A pressure-controlled beveled glass pipette
(Drummond (Broomall, PA, USA), WPI Microbeveller
(Sarasota, FL, USA)) was used for injection. After each
injection, the embryos were moistened with PBS and
voltage steps via tweezertrodes (BTX, 5 mm round, pla-
tinum, BTX electroporator (Holliston, MA, USA)) were
applied at a 30 to 45 degree angle with respect to the
interaural line to target CA3. Voltage was 36V for 5
pulses at 1 Hz, each pulse lasting 50 ms.
Imaging and analysis of spines
Spines were imaged on a Leica SP2 or SP5 confocal
microscope under 63 × magnification with 3 × optical
zoom for imaging of TE spines and 4 × optical zoom
for imaging of classical spines. Images were collected
from clearly identifiable pyramidal neurons throughout
the extent of CA3 with TE spine images collected on
primary and secondary dendrites and classic spine
images collected on tertiary branches in the middle
third of the CA3 stratum radiatum. Images were col-
lected as z-stacks with 0.5 μm thick sections. Images
were analyzed as confocal stacks using ImageJ software.
For all spines, individual spine heads were identified and
analyzed in the confocal plane in which they had the
largest area. Head width measurements were obtained
using a custom ImageJ plugin called edgefitter [47].
Individual multi-headed spines cannot be separated at
the light level, but individual spine heads could be reli-
ably separated using high-resolution confocal stacks and
our analysis is of overall TE spine head density.
Lentivirus production
Lentivirus was made by transfecting 293T cells with the
pFCK(0.4)GW plasmid along with helper plasmids
(psPAX2 and VSVG). After 3 days, 293T media was
centrifuged (46,000 × g) to concentrate the virus, resus-
pended in PBS, and stored at -80°C. For in vivo injec-
tions, P5 rat pups of either sex were anesthetized using
an isoflurane vaporizer and immobilized in a stereotaxic
device. Following craniotomy, a Hamilton syringe was
used to inject 1 μl of concentrated virus. The animals
were sutured and returned to their cage until further
analysis.
Electrophysiology
Whole-cell, voltage-clamp recordings were performed on
CA3 pyramidal neurons in acute brain slices from Neu-
roD2 null mice and littermate controls. Mice of either sex
aged P14 to P17 were deeply anesthetized with isoflurane
and then rapidly decapitated. Brain slices were cut in the
sagittal plane at a thickness of 350 μmu s i n gav i b r a t i n g
microtome (VT-1200, Leica Microsystems, Bannockburn,
IL, USA). Slicing was performed in an ice-cold artificial
cerebral spinal fluid with the following ionic composition
(concentrations in mM): NaCl 124, KCl 5, NaHCO3 26,
NaH2PO4 1.25, glucose 10, MgCl2 6, CaCl2 1. Slices were
moved directly to a holding chamber and maintained for
at least 0.5 hours (0.5 to 3 hours), and then transferred to
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chambers, slices were submerged in a standard artificial
cerebral spinal fluid solution (at room temperature) with
the following ionic composition (in mM): NaCl 124, KCl
5, NaHCO3 26, NaH2PO4 1.25, glucose 10, MgCl2 3,
CaCl2 2, and bubbled constantly with 95% O2:5% CO2 gas.
Our recording solution also contained 100 μM picrotoxin
(Tocris Bioscience (Minneapolis, MN, USA)) to block
GABA receptor-mediated inhibitory currents. CA3 pyra-
midal neurons were visualized by infrared differential
interference contrast imaging using an upright, fixed-stage
microscope (BX-51, Olympus (Center Valley, PA, USA)).
Whole-cell patch electrodes were pulled from borosilicate
glass (1.5 mm outer diameter and 1.16 mm inner dia-
meter, Warner Instruments (Hamden, CT, USA)) to resis-
tances ranging from 3 to 6 MΩ. Access resistance was
monitored for consistency during recordings and ranged
from 10 to 20 MΩ for the cells included for analysis. The
intracellular recording solution contained (in mM): CsCl
20, CsMeSO3 105, ATP (dipotassium salt) 0.5, GTP 0.3,
Hepes 10, MgCl2 2, EGTA 1, QX-314 2 and BAPTA 10, at
pH 7.3. Recordings were acquired using a PC-505 ampli-
fier (Warner Instruments (Hamden, CT, USA)) and digi-
tized using custom software routines written in Igor Pro
(Wavemetrics (Portland, OR, USA)) and the NIDAQ tools
package, to access a PCI-based board (PCI-1200, National
Instruments (Austin, TX, USA)) on a Macintosh G3
computer.
Hippocampal culture
Hippocampal neurons were cultured from P0 WT and
NeuroD2 null mouse littermates of either sex. The
whole hippocampus, including DG, CA3 and CA1
regions, was dissected free from the cortex, and neurons
were dissociated and plated on a rat glial monolayer
previously cultured on poly-D-lysine (Millipore, Teme-
cula, CA, USA) and laminin (Invitrogen, Carlsbad, CA,
USA) coated coverslips. Neurons were maintained in
Neurobasal-A medium (Invitrogen) supplemented with
B27, glucose, glutamax, penicillin/streptomycin (Invitro-
gen) and 25 μM B-mercaptoethanol.
Immunohistochemistry
For LY immunohistochemistry, slices were blocked 1
hour at room temperature in 3% bovine serum albumin
+ 0.3% Triton X-100 in PBS and incubated in primary
antibody against LY (Abcam, rabbit anti-LY (Cambridge,
MA, USA); 1:1,000) overnight at 4°C in blocking solu-
tion. Slices were then washed three times for 20 minutes
each with blocking solution and incubated in secondary
antibody (Molecular Probes, donkey anti-rabbit 555
(Grand Island, NY, USA); 1:1,000) for 2 hours at room
temperature. Finally, slices were labeled with a Hoechst
nuclear stain and mounted on slides for confocal
microscopy. For virally labeled neurons, slices were
simultaneously incubated with primary antibody against
GFP (Abcam, goat anti-GFP; 1:3,000) and stained with a
secondary antibody in the far red channel (Molecular
Probes, donkey anti-goat 647, 1:1,000).
For immunohistochemistry in slices from WT and
NeuroD2 null mice, animals of either sex were transcar-
dially perfused as for microinjection of LY, but were
post-fixed overnight at 4°C. Slices for immunohistochem-
istry were saturated with a 30% sucrose in PBS solution
for approximately 3 days and flash frozen in dry ice
before cutting 30 μm frozen sections on a cryostat micro-
tome. Slices were then blocked with 3% bovine serum
albumin in PBS for 1 hour before being incubated in pri-
mary antibody overnight at 4°C, washed and incubated
with fluorophore conjugated secondary antibody for 2
hours at room temperature, and washed and incubated
with Hoechst nuclear stain before being coverslipped.
Cultured neurons were fixed in 4% paraformaldehyde,
4% sucrose in PBS and processed for immunofluores-
cence according to standard procedures. Cells were
washed with PBS and incubated in blocking solution
(PBS plus 3% bovine albumin and 0.1% TritonX 100) for
30 minutes. For SPO staining only, 0.1% Saponin was
included only in the preliminary blocking step. Then
cells were incubated in primary antibody diluted in
blocking solution for 2 hours, washed, incubated in sec-
ondary antibody diluted in blocking solution for 1 hour,
washed again and stained with Hoechst nuclear stain
before being coverslipped. Primary antibodies were: rat
anti-CTIP2 1:1,000 (Abcam), rabbit anti-synaptoporin
1:1,000 (Synaptic Systems, (Goettingen, Germany)),
mouse anti-PSD95 1:250 (NeuroMAB, (Davis, CA,
USA)), guinea-pig anti-Vglut1 1:5,000 (Chemicon, (Bill-
erica, MA, USA)), Chicken anti-MAP2 1:5,000 (Abcam).
Fluorophore-conjugated secondary antibodies were from
Jackson ImmunoResearch (West Grove, PA, USA) or
Invitrogen and were used at 1:1,000.
Image acquisition and analysis of in vitro experiments
Images were captured on Leica SP2 and SP5 confocal
microscopes (Leica Microsystems (Buffalo Grove, IL,
USA)). Z-Stacks were collapsed in a maximum projec-
tion and analyzed using NIH ImageJ software. Images
were thresholdeded using constant settings per experi-
ment and colocalized synaptic markers were quantified
per unit length of dendrite using an automated method
of assessing pixel overlap.
Immunoblotting and quantification
Western blotting was performed by standard proce-
dures. For hippocampal lysates, mice of either sex were
decapitated under isoflurane anesthesia, and the hippo-
campus was dissected free in cold PBS and
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293T expression experiments cells were lysed directly in
hot SDS containing sample buffer and boiled for 10
minutes. Lysates were diluted into SDS containing sam-
ple buffer, boiled for 10 minutes and run by SDS-PAGE.
Antibodies used for immunoblotting were the following:
mouse anti-myc, 1:1,000 (Santa Cruz Biotechnology
(Santa Cruz, CA, USA)), mouse anti-PSD95 1:1,000
(Affinity Bioreagents ABR (Rockford, IL, USA)), mouse
anti-bIIItubulin 1:1,000 (Abcam), mouse anti-GAPDH
1:5,000 (Millipore (Billerica, MA, USA)), mouse anti-
Pick1 1:500 (NeuroMAB), mouse anti-SAP102 1:1,000
(NeuroMAB), rabbit anti-GluR2 1:1,000 (Chemicon),
mouse anti-NR2A 1:1,000 (Chemicon), mouse anti-
NR2B 1:1,000 (NeuroMAB), rat anti-synaptoporin
1:1,000 (Synaptic Systems), rabbit anti-CKII 1:1,000
(Upstate Biotechnology (Billerica, MA, USA)), rabbit
anti-BDNF 1:1,000 (Santa Cruz Biotechnology). Immu-
noblotting and quantification for SynCAM1 to -3 were
performed as previously described [48]. Quantification
of other immunoblots was by measurement of densito-
metry in standard sized windows, using imageJ software.
Quantitative PCR experiments
Mouse cortical neurons were taken from embryonic 15
day pups of either sex, cultured in Neural Basal Medium
with B27 and stimulated with indicated methods at 3 and
12 days in vitro, respectively. Total RNA was collected 3
hours after stimulation and reverse-transcribed to cDNA.
Real-time PCR are performed with SYBR-Green dye on
Rotor-Gene Q (Qiagen (Valencia, CA, USA)). Statistical
analysis is done with software with Rotor-Gene.
Additional material
Additional file 1: Some synaptic proteins are unaffected in the
NeuroD2 null hippocampus. (A) Representative immunoblots against
hippocampal lysates from P21 WT and NeuroD2 null littermates. (B)
Quantification of immunoblots against a number of pre- and post-
synaptic proteins, which are unaffected in the NeuroD2 null
hippocampus. No comparisons reached statistical significance, n = 2
littermate pairs. Error bars represent standard error of the mean.
Additional file 2: NeuroD2 regulates the expression of SynCAM1 to
-3 in the developing hippocampus. (A) Immunoblots against
SynCAM1, 2 and 3 from hippocampal lysates from WT and NeuroD2 null
littermates at P14 and P21. Loading control is immunoblot against
synaptophysin/p38. (B) Quantification of SynCAM1 expression. (C)
Quantification of SynCAM2 expression. (D) Quantification of SynCAM3
expression. *P < 0.05, **P < 0.01, ***P < 0.001, t-test. Error bars represent
standard error of the mean. N = 1 littermate pair at P14 and 2 littermate
pairs at P21.
Additional file 3: Potential NeuroD2 binding sites upstream of
PSD95 and SAP102. Table listing sites within approximately 2 kb
upstream of transcriptional start sites for PSD95 and SAP102 that
conform to a consensus E-Box site to which NeuroD2 binds (CANNTG).
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